Maia Drug Patent Portfolio
Maia owns 3 orange book drugs protected by 10 US patents Given below is the list of Maia's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11679119 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US11752164 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US12005069 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US11903993 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US11918622 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US11992514 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US12472224 | Ready-To-Use Bivalirudin Compositions | 20 May, 2039 | Active |
| US11110063 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
| US11318100 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
| US11737983 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
Latest Legal Activities on Maia's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Maia.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Date Forwarded to Examiner | 20 Aug, 2025 | US12472224 |
| Response after Non-Final Action | 12 Aug, 2025 | US12472224 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED | 12 Aug, 2025 | US12472224 |
| Terminal Disclaimer Filed | 12 Aug, 2025 | US12472224 |
| Email Notification | 01 Aug, 2025 | US12472224 |
| Mail Non-Final Rejection | 01 Aug, 2025 | US12472224 |
| Electronic Review | 01 Aug, 2025 | US12472224 |
| Non-Final Rejection | 30 Jul, 2025 | US12472224 |
| Information Disclosure Statement considered | 15 Jul, 2025 | US12472224 |
| Date Forwarded to Examiner | 03 Jul, 2025 | US12472224 |
| Response to Election / Restriction Filed | 27 Jun, 2025 | US12472224 |
| Electronic Review | 21 May, 2025 | US12472224 |
| Email Notification | 21 May, 2025 | US12472224 |
| Mail Restriction Requirement | 21 May, 2025 | US12472224 |
| Restriction/Election Requirement | 19 May, 2025 | US12472224 |
Maia's Family Patents
Maia Drug List
Given below is the complete list of Maia's drugs and the patents protecting them.
1. Angiomax Rtu
Angiomax Rtu is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11903993 | Ready-to-use bivalirudin compositions |
20 May, 2039
(13 years from now)
| Active |
| US11918622 | Ready-to-use bivalirudin compositions |
20 May, 2039
(13 years from now)
| Active |
| US11992514 | Ready-to-use bivalirudin compositions |
20 May, 2039
(13 years from now)
| Active |
| US12472224 | Ready-To-Use Bivalirudin Compositions |
20 May, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Angiomax Rtu's drug page
2. Bortezomib
Bortezomib is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11679119 | Bortezomib compositions |
23 Sep, 2042
(16 years from now)
| Active |
| US11752164 | Bortezomib compositions |
23 Sep, 2042
(16 years from now)
| Active |
| US12005069 | Bortezomib compositions |
23 Sep, 2042
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bortezomib's drug page
3. Sincalide
Sincalide is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11110063 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
| US11318100 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
| US11737983 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sincalide's drug page